Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prion therapeutics: Lessons from the past
Kyu-Hwan Shim, Niti Sharma, Seong Soo A. An
Prion (2022) Vol. 16, Iss. 1, pp. 265-294
Open Access | Times Cited: 15

Showing 15 citing articles:

Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
Rohan Gupta, Dia Advani, Divya Yadav, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 11, pp. 6476-6529
Closed Access | Times Cited: 20
Exploring immunotherapeutic strategies for neurodegenerative diseases: a focus on Huntington’s disease and Prion diseases
Abhiyanta Mukherjee, Soumojit Biswas, Ipsita Roy
Acta Pharmacologica Sinica (2025)
Closed Access
Idebenone improves mitochondrial respiratory activity and attenuates oxidative damage via the SIRT3-SOD2 pathway in a prion disease cell model
Zhixin Sun, Pei Wen, Dongming Yang, et al.
Life Sciences (2025) Vol. 366-367, pp. 123481-123481
Closed Access
Potential Therapeutic Use of Stem Cells for Prion Diseases
Mohammed Zayed, Sung‐Ho Kook, Byung‐Hoon Jeong
Cells (2023) Vol. 12, Iss. 19, pp. 2413-2413
Open Access | Times Cited: 7
What Are the Roles of Cellular Prion Protein in Normal and Pathologic Conditions?
Eduardo E. Benarroch
Neurology (2024) Vol. 102, Iss. 7
Closed Access | Times Cited: 2
Therapeutic advances in neuroinfectious diseases
Rumyar Ardakani, Lucy Jia, Elizabeth Matthews, et al.
Therapeutic Advances in Infectious Disease (2024) Vol. 11
Open Access | Times Cited: 2
Human prion diseases - state of the art 2023
Egon Kurča, Štefan Sivák, Pavol Skáčik
Neurologie pro praxi (2024) Vol. 25, Iss. 1, pp. 19-25
Closed Access | Times Cited: 1
Adaptation of the protein misfolding cyclic amplification (PMCA) technique for the screening of anti‐prion compounds
Katherine Do, Rebeca Benavente, Celso S. G. Catumbela, et al.
The FASEB Journal (2024) Vol. 38, Iss. 14
Open Access | Times Cited: 1
Isolation of Anti-Prion Compounds from Curcuma phaeocaulis Valeton Extract
Jaehyeon Kim, Hakmin Lee, Hye mi Kim, et al.
Molecules (2024) Vol. 29, Iss. 17, pp. 4034-4034
Open Access
Potential of Marine Sponge Metabolites against Prions: Bromotyrosine Derivatives, a Family of Interest
Maha Sinane, Colin Grunberger, Lucile Gentile, et al.
Marine Drugs (2024) Vol. 22, Iss. 10, pp. 456-456
Open Access
Overview of human transmissible spongiform encephalopathies
Rebeca Benavente, Celso S. G. Catumbela, Rodrigo Morales
Elsevier eBooks (2024), pp. 529-545
Closed Access
Therapeutic perspectives for prion diseases in humans and animals
Rebeca Benavente, Rodrigo Morales
PLoS Pathogens (2024) Vol. 20, Iss. 12, pp. e1012676-e1012676
Open Access
Radotinib Decreases Prion Propagation and Prolongs Survival Times in Models of Prion Disease
Yeong‐Gon Choi, Byungki Jang, Jeong‐Ho Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12241-12241
Open Access | Times Cited: 1
Possible Treatments for COVID Vaccine Induced Prion Disease
Bart Classen J
Recent Advances in Clinical Trials (2023) Vol. 3, Iss. 2
Open Access | Times Cited: 1
Miscellaneous CNS Viral Infections: Underappreciated Causes of Neurologic Disease
Hiba Sami, Safiya Firoze, Parvez Anwar Khan
(2023), pp. 205-246
Closed Access
Page 1

Scroll to top